Abrégé

An animal feed additive composition comprises an effective amount of a laidlomycin, a carrier, magnesium sulfate, and silicon dioxide. Other embodiments include methods of making the animal feed additive compositions, and the use of a laidlomycin in the manufacture of an animal feed additive for increasing the efficiency of feed utilization and rate of weight gain in domestic animals.

Classes IPC  ?

• A61K 31/35 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle

Abrégé

Disclosed herein are purified bacteriophage preparations that effectively lyse a plurality of C. perfringens strains. In one embodiment, a purified bacteriophage preparation includes four or more C. perfringens-specific bacteriophage, wherein each bacteriophage has lytic activity against at least five C. perfringens strains. In another embodiment, the purified bacteriophage preparation includes five or more C. perfringens-specific bacteriophage.

Classes IPC  ?

• C12N 7/01 - Virus, p. ex. bactériophages, modifiés par l'introduction de matériel génétique étranger
• C12N 7/02 - Isolement ou purification
• G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
• C12R 1/145 - Clostridium
• C12R 1/19 - Escherichia coli
• C12R 1/92 - Virus

Abrégé

Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided.

Classes IPC  ?

• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 31/135 - Amines, p. ex. amantadine ayant des cycles aromatiques, p. ex. méthadone
• A61K 31/485 - Dérivés du morphinane, p. ex. morphine, codéine

Abrégé

Disclosed is a multiparticulate in-feed additive composition comprising praziquantel or a salt thereof and cimetidine or a salt thereof, a medicated fish-feed comprising the multiparticulate in-feed additive composition, and a method of eliminating or reducing or preventing parasites in a fish population.

Classes IPC  ?

• A61K 31/498 - Pyrazines ou pipérazines condensées en ortho ou en péri avec des systèmes carbocycliques, p. ex. quinoxaline, phénazine
• A61K 9/32 - Revêtements organiques contenant des polymères synthétiques solides
• A61K 9/34 - Revêtements organiques contenant des gommes ou résines naturelles
• A61K 9/58 - Revêtements organiques contenant des polymères synthétiques solides
• A61K 9/60 - Revêtements organiques contenant des gommes ou des résines naturelles
• A61K 31/415 - 1,2-Diazoles

Abrégé

Disclosed is a multiparticulate in- feed additive composition comprising Emamectin or a salt thereof, a method of manufacturing the multiparticulate in- feed additive composition, a medicated fish- feed comprising the multiparticulate in- feed additive composition, and a method of eliminating or reducing or preventing parasites in a fish population.

Classes IPC  ?

• A61K 9/52 - Préparations en capsules, p. ex. de gélatine, de chocolat du type à libération prolongée ou discontinue
• A61K 9/36 - Revêtements organiques contenant des hydrates de carbone ou leurs dérivés
• A61K 9/62 - Revêtements organiques contenant des hydrates de carbone ou leurs dérivés
• A61K 31/70 - Hydrates de carboneSucresLeurs dérivés
• A61K 47/30 - Composés macromoléculaires organiques ou inorganiques, p. ex. polyphosphates inorganiques
• A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
• A61K 47/38 - CelluloseSes dérivés

Abrégé

An animal feed additive composition comprises an effective amount of a maduramicin ammonium, a carrier, a binder, and optionally a pH regulator. Other embodiments include methods of making the animal feed additive compositions, and the use of a maduramicin in the manufacture of an animal feed additive for treating coccidiosis.

Classes IPC  ?

• A23K 1/00 - Produits alimentaires pour animaux
• A23K 1/17 - avec des antibiotiques
• A23K 1/18 - spécialement conçus pour des animaux déterminés

Abrégé

Disclosed herein are tetracycline medicated feed premixes and methods for the stabilization thereof. In one embodiment, a medicated feed premix comprises 15 wt% to 65 wt% of a pharmaceutically acceptable chlortetracycline hydrochloride, 20 wt% to 85 wt% of a carrier, and 0.1 wt% to 10 wt% of a binder, wherein all amounts are based on the total weight of the animal feed supplement. Also included are methods of making a medicated feed premix, the use of a chlortetracycline hydrochloride in the manufacture of a medicament for treating microbial infections in animals, and an animal feed composition.

Classes IPC  ?

• A61K 31/065 - Alcools acycliques diphényl-substitués
• A61K 9/16 - AgglomérésGranulésMicrobilles

Abrégé

Provided herein is a method of treating a condition in a host that is responsive to an agonist, the method comprising administering to the host a multi-layer pharmaceutical composition comprising the agonist eg. an opioid and an antagonist eg. naltrexone thereof, wherein the agonist and antagonist are not in direct contact with one another in the intact form of the composition.

Classes IPC  ?

• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 9/50 - Microcapsules
• A61K 31/485 - Dérivés du morphinane, p. ex. morphine, codéine
• A61P 25/04 - Analgésiques centraux, p. ex. opioïdes
• A61P 25/36 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance aux opiacés